Doping with aromatase inhibitors and oestrogen receptor modulators in steroid users: Analysis of a forum to identify dosages, durations and adverse drug reactions.

Rochoy M, Danel A, Chazard E, Gautier S, Berkhout C

Open source

DOI
10.1016/j.therap.2022.03.004
Published
2022 Nov-Dec
Container
Therapie
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.therap.2022.03.004,
  title = {Doping with aromatase inhibitors and oestrogen receptor modulators in steroid users: Analysis of a forum to identify dosages, durations and adverse drug reactions.},
  author = {Rochoy M and Danel A and Chazard E and Gautier S and Berkhout C},
  year = {2022},
  journal = {Therapie},
  doi = {10.1016/j.therap.2022.03.004},
  url = {https://doi.org/10.1016/j.therap.2022.03.004}
}

RIS

TY  - JOUR
TI  - Doping with aromatase inhibitors and oestrogen receptor modulators in steroid users: Analysis of a forum to identify dosages, durations and adverse drug reactions.
AU  - Rochoy M
AU  - Danel A
AU  - Chazard E
AU  - Gautier S
AU  - Berkhout C
PY  - 2022
JO  - Therapie
DO  - 10.1016/j.therap.2022.03.004
UR  - https://doi.org/10.1016/j.therap.2022.03.004
ER  - 

APA

M, R., A, D., E, C., S, G., & C, B. (2022). Doping with aromatase inhibitors and oestrogen receptor modulators in steroid users: Analysis of a forum to identify dosages, durations and adverse drug reactions.. Therapie. https://doi.org/10.1016/j.therap.2022.03.004

Source records